Tag: Business
Medicare Obesity Drug Coverage and 340B Analysis: Pharmalittle Updates
Good day, everyone! We hope you are all well despite the rainy weather. Remember, each day is a gift waiting to be unwrapped. As we take a short break for the upcoming holiday, let's...
Sutter Health CEO Donates to Harris in Wake of Antitrust Investigation
Sutter Health's CEO, Warner Thomas, recently made significant donations to Vice President Harris' presidential campaign and the Democratic National Committee. Despite Harris' involvement in an antitrust investigation against Sutter Health in the past, Thomas...
Biotech News Roundup: Stay Updated on the Latest Developments in the Industry
Good morning, everyone! Today, we have some interesting updates from the biotech industry. The BIOSECURE Act is facing a crucial moment as it needs to be passed by Congress by December to avoid obstacles,...
Biotech Outlook Post-Trump Presidency: What’s Next?
Adam: Hey Matt, glad you could join me today. The future of the biotech industry post-Trump presidency is something that many are curious about. One key aspect that everyone is keeping an eye on...
FAQs: Understanding IGAs in Animals
Intentional Genomic Alterations (IGAs) in animals refer to changes made to an animal's DNA using modern molecular technologies. These alterations can include targeted DNA sequence changes like insertions, substitutions, or deletions, among others. Common...
Merck Expands Portfolio with Licensing of Chinese Cancer Drug
Merck, a leading pharmaceutical company, has recently taken a strategic step to enhance its cancer drug portfolio by acquiring the licensing rights for a new cancer drug from LaNova Medicines, a Chinese firm based...
The Main Target and Focus: The article focuses on key figures attending the J.P....
Highlights from J.P. Morgan Healthcare Conference Day 2 The J.P. Morgan Healthcare Conference on Day 2 saw a flurry of activity, with key industry figures making headlines and sharing insights that could shape the future...
FDA Plans to Ban Cold Medicine, Eisai’s Alzheimer’s Drug Sales, and More: Pharmalittle Update
As we approach the end of another workweek, it's time to start thinking about weekend plans. Our schedule includes tending to the Pharmalot grounds, spending time with our beloved mascots, and catching up on...
Ending 23andMe’s Drug Discovery Dream: What Went Wrong?
23andMe, the genetics company that many people have been excited about, recently made a big announcement. The company has decided to stop working on creating new medicines and will be letting go of 40%...
Pharmacies Sue GoodRx and PBMs for Illegal Reimbursement Fees
Three independent pharmacies recently took legal action against GoodRx, a company that offers a prescription drug discount card, as well as several pharmacy benefit managers (PBMs). These lawsuits allege that GoodRx and the PBMs...
GSK Withdraws from BIO, Signaling Major Setback for Lobbying Group
Pharmaceutical company GSK has announced its decision to leave the Biotechnology Innovation Organization (BIO), which is the largest trade group in the biotechnology industry. This move by GSK marks a significant setback for the...
AI Drug Development Company Recursion Cuts Jobs Post Exscientia Merger
Recursion Pharmaceuticals, a company known for its innovative use of artificial intelligence and machine learning in drug development, recently made the decision to lay off employees following a merger with Exscientia. This move comes...
